Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 P456

ECE2006 Poster Presentations Endocrine tumours and neoplasia (116 abstracts)

Prognostic value of KI-67 expression in the cytologic identification of pancreatic endocrine tumors: preliminary data

MF Manzoni , GM Franchi , C Piani , C Cappelletti , PG Arcidiacono , L Albarello , C Doglioni & E Bosi


S. Raffaele Scientific Institute, Milan, Italy.


Background: Organ infiltration and metastasis are the only parameters defining malignancy of pancreatic endocrine tumors. Several studies had demonstrated the prognostic value of Ki-67 expression measured on histological sections obtained from the removed pancreatic endocrine tumors. We postulate that Ki-67 expression measured on fine needle aspiration cytology provides pre-operative indications of the malignancy of pancreatic endocrine tumors.

Aim: Aims of this study were: 1) to examine the feasibility of measuring expression of Ki-67 on fine needle aspiration cytology; and 2) to compare the measurements of Ki-67 expression obtained on fine needle aspiration cytology and histological sections from the removed tumor.

Methods: We measured Ki-67 expression on endoscopic ultrasonography fine needle aspiration cytology performed for diagnostic purposes and histological sections obtained after surgical removal of the tumor in ten patients with pancreatic endocrine tumors.

Results: Adequate aspirate volumes were available on 6 out of 10 patients. Expression of Ki-67 was 20%, 15%, 1%, <1%, 1–2%, <1% in cytology and 15%, 19%, <1%, <1%, 2%, <1% in histology, respectively.

Conclusions: The results of this pilot study suggest that measurement of Ki-67 expression is feasible on fine needle aspiration cytology and there is a good category agreement of Ki-67 expression between endoscopic ultrasonography fine needle aspiration cytology and histological sections of the tumor. If our results are confirmed in a larger study, Ki-67 expression on cytology may help to discriminate between low and medium/high proliferative tumors and used for prognostic and therapeutic pre-operative evaluation of endocrine pancreatic tumors.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.